Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endocrine Gland Neoplasms × Phlebotomy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 5 Polycythemia Vera 4 Lung Neoplasms 4 Myeloproliferative Disorders 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Lymphoma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Thymic aplasia 1 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Sarcoma 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Pancreatitis, Chronic 1 Pancreatitis 1 Pancreatic Cyst 1

Interventions

Gemcitabine 4 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 selpercatinib 2 napabucasin 2 entinostat 2 Ocoxin 2 temsirolimus 1 tariquidar 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 lutetium Lu 177 dotatate 1 irinotecan sucrosofate 1 ganitumab 1 copper dotatate CU-64 1 Valproic Acid 1 Therapeutic Irrigation 1 Taxes 1 Sunitinib 1 Staining and Labeling 1 Sirolimus 1 Psilocybin 1 Phlebotomy 1 Paclitaxel 1 Oxaliplatin 1 Lutetium-177 1 Lutetium 1 Leucovorin 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07121998 2025-08-14

PROGRESS-TMZ

Uppsala University

Endocrine Gland Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡